ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP05

Fighting Health-Related Misinformation Using Social Media / How Creating an Online Group for Patients with Relapsing Polychondritis — and Moderating It with Health Professionals — Helps Spread Reliable and Empowering Information

Michael Linn1, Spenser Mestel2 and Susie Ratledge3, 1Relapsing Polychondritis Foundation, New York, NY, 2New York, NY, 3Relapsing Polychondritis: Secular Science and Support group, Chattanooga, TN

Meeting: ACR Convergence 2021

Keywords: autoimmune diseases, cartilage, Cartilage Degradation, education, medical, education, patient

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 7, 2021

Title: Patient Perspectives Poster (PP01–PP09)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Before I became ill in 2017, I was a registered nurse with a degree in health science who’d often educate patients about how they could better live with their disease by understanding it. In my career, I served as a Health Education Coordinator, for the benefit of patients and communities, and was certified in diabetes education. So, when I was diagnosed with relapsing polychondritis (“RP”) in 2018, I began to do my own research.

Unfortunately, RP is a rare disease, and though my rheumatologist was relatively well informed about it, many doctors are unaware of the the case studies and (albeit few) larger population studies. In this vacuum of knowledge, patients often seek out and fall prey to misinformation. For example, one doctor (commonly found on the internet) touts a diet that “cures” RP. While I certainly encourage others to eat healthy and exercise regularly, there can be significant danger in forgoing legitimate medical treatment in order to pursue unproven cures. Likewise, even well-meaning patients often present their own experiences as if they’re proof of the success of a medication or lifestyle change.

Intervention: Troubled by the lack of peer-reviewed science and anecdotal evidence in some other online support groups, I created an online community for RP patients. Along with five other moderators, including two health professionals, we vet the information provided. First and foremost, we ensure that it’s coming from a reputable source, and that it’s accessible to laypeople. I’ll listen to dozens of lectures and comb through pages of results from online archives of biomedical and life science journal literature before I post something to the group.

To provide consistent and practical information, we also do “Monday Meds,” where we discuss the different medications for autoimmune disease, and “Favorite Things Friday,” where we list what we’re grateful for, like pillows with a hole in the center, which helps to relieve the pressure on our ears when sleeping.

However, it’s not just about the quality of the information. Given all of us have spent years interacting with fellow RP patients, we’ve established trust and rapport within the community, allowing us to both highlight reputable sources and to gently discourage misinformation.

Maintenance: Through this group, we’ve been able to equip patients with knowledge to bring to their doctors, empowering them to positively influence their own care. Similarly, we’re able to prevent them from getting their hopes up about untested treatments. We offer an evidence-based, community-minded approach that has improved the quality of life for our members and for me.

Quality of Life: By offering both current scientific research and emotional support, our online group addresses the emotional and health-related needs of our community, which would otherwise go unmet for most of us.

Relapsing Polychondritis: Secular Science and Support Group

Susie Ratledge, Presenting Author

Relapsing Polychondritis Foundation


Disclosures: M. Linn, None; S. Mestel, None; S. Ratledge, None.

To cite this abstract in AMA style:

Linn M, Mestel S, Ratledge S. Fighting Health-Related Misinformation Using Social Media / How Creating an Online Group for Patients with Relapsing Polychondritis — and Moderating It with Health Professionals — Helps Spread Reliable and Empowering Information [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/fighting-health-related-misinformation-using-social-media-how-creating-an-online-group-for-patients-with-relapsing-polychondritis-and-moderating-it-with-health-professionals/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fighting-health-related-misinformation-using-social-media-how-creating-an-online-group-for-patients-with-relapsing-polychondritis-and-moderating-it-with-health-professionals/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology